NasdaqGM - Delayed Quote USD
Keros Therapeutics, Inc. (KROS)
14.02
+0.31
+(2.26%)
At close: May 8 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 7 |
| Avg. Estimate | -1.17 | -0.96 | 0.34 | -4.39 |
| Low Estimate | -1.3 | -1.35 | -0.6 | -6.02 |
| High Estimate | -1.08 | -0.82 | 0.94 | -2.93 |
| Year Ago EPS | -1.25 | -1.41 | -5 | 0.34 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 8 | 10 |
| Avg. Estimate | 344.44k | 2.86M | 216.22M | 6.57M |
| Low Estimate | -- | -- | 211.2M | -- |
| High Estimate | 3M | 12.65M | 231.2M | 40M |
| Year Ago Sales | 37k | 388k | 3.55M | 216.22M |
| Sales Growth (year/est) | 830.92% | 637.40% | 5,990.64% | -96.96% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.25 | -1.28 | -0.43 | 0.01 |
| EPS Actual | -1.25 | -1.41 | -1.14 | 3.62 |
| Difference | 0 | -0.13 | -0.71 | 3.61 |
| Surprise % | 0.20% | -10.52% | -166.98% | 48,166.67% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.17 | -0.96 | 0.34 | -4.39 |
| 7 Days Ago | -1.11 | -0.98 | -3.2 | -4.13 |
| 30 Days Ago | -1.12 | -1 | -3.16 | -4.23 |
| 60 Days Ago | -1.11 | -0.9 | -2.4 | -3.75 |
| 90 Days Ago | -1.29 | -1.16 | -3.64 | -4.31 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KROS | 6.40% | 31.91% | 106.75% | -1,401.59% |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/8/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/9/2025 |
| Reiterates | Wedbush: Neutral to Neutral | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/27/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
Related Tickers
HLVX HilleVax, Inc.
1.9100
+3.24%
ASMB Assembly Biosciences, Inc.
11.66
-6.04%
RPTX Repare Therapeutics Inc.
1.3600
0.00%
SPRO Spero Therapeutics, Inc.
0.5750
-0.52%
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%
EPIX ESSA Pharma Inc.
1.7100
-1.16%
IPSC Century Therapeutics, Inc.
0.5200
-0.34%
VTYX Ventyx Biosciences, Inc.
1.1700
-3.31%
KRON Kronos Bio, Inc.
0.7298
+1.33%
LXEO Lexeo Therapeutics, Inc.
3.0000
+0.33%